Complementary Therapy: Integrating nebulized glutathione into existing treatment protocols complements conventional therapies for respiratory conditions such as asthma, COPD, and bronchitis, enhancing their efficacy and improving patient outcomes
Zhou Z, Wang J, Xu X, Wang Z, Mao L, Zhang S, Zhang H, Li Y, Yu Q, Jiang N, Zhang G, Gan Z, Ning Z (2024) Lignin-based nanoparticles for combination of tumor oxidative stress amplification and reactive oxygen species responsive drug release
Loperamide (Imodium) is sometimes appropriate for short-term symptom control, but should only be used after talking to your clinician it can mask warning signs of more serious GI issues
Phase 3 results are expected throughout the remainder of the TRIUMPH program, with potential FDA approval estimated for 2027 at the earliest
Glutathione, TCA (Trichloroacetic Acid), Retinoic Acid, Salicylic Acid, Kojic Acid, Phenol, Vitamin C